In this article, we take a look at five stocks that are gaining ground on Tuesday. If you want to take a look at some more stocks that are rising and the latest market situation, go to 10 Stocks Gaining Ground on Tuesday.
5. Advanced Micro Devices, Inc. (NASDAQ:AMD) has risen 7.66% as of 11:42 AM ET after Harsh Kumar at Piper Sandler upgraded Advanced Micro Devices, Inc. (NASDAQ:AMD) from a Neutral to an Overweight rating. The analyst also raised the price target on Advanced Micro Devices, Inc. (NASDAQ:AMD) from $98 to $140. Kumar shared that Advanced Micro Devices, Inc.’s (NASDAQ:AMD) mid to long-term catalysts remain strong amid healthy semi-custom and server trends.
Overall, 69 hedge funds reported owning a stake in Advanced Micro Devices, Inc. (NASDAQ:AMD) at the end of Q4 2021.
4. JD.com, Inc. (NASDAQ:JD) is up 2.41% as of 11:58 AM ET after the Chinese Vice Premier’s meeting with tech officials today raised hopes regarding ease in crackdown on the tech sector. The Chinese government is expected to lighten regulations regarding anti-trust and data protection laws. Moreover, JD.com, Inc. (NASDAQ:JD) recorded a profit of 2.53 yuan per ADS for the quarter ended March 31, higher than the analysts’ estimate of 1.62 yuan.
Out of the 924 hedge funds in Insider Monkey’s database, 67 funds held a stake in JD.com, Inc. (NASDAQ:JD) as of Q4 2021. Tiger Global Management LLC was long over 48 million shares of JD.com, Inc. (NASDAQ:JD) during Q1 2022.
3. Moderna, Inc. (NASDAQ:MRNA) has climbed 4.37% as of 12:12 PM ET after the biotechnology company made announcements today regarding the expansion of its mRNA platform. Moderna, Inc. (NASDAQ:MRNA) is focusing on delivery systems that target pulmonary diseases. A new LNP formulation has been developed by Moderna, Inc.’s (NASDAQ:MRNA) researchers to counter the issues linked with mRNA’s lung delivery. Investors are bullish on the stock as Moderna, Inc. (NASDAQ:MRNA) appears to be in a strong position to develop innovative solutions and new clinical applications.
At the end of Q4 2021, Moderna, Inc. (NASDAQ:MRNA) was being held by 43 hedge funds.
2. Harpoon Therapeutics, Inc. (NASDAQ:HARP) has surged 14.83% as of 12:31 PM ET after the price target on the biotech company was raised from $14 to $18 by Zegbeh Jallah at Roth Capital. The analyst reiterated a Buy rating on Harpoon Therapeutics, Inc. (NASDAQ:HARP). Jallah revealed that Harpoon Therapeutics, Inc. (NASDAQ:HARP) is expanding its clinical programs while placing greater importance on DLL3 and BCMA.
As of Q4 2021, 14 hedge funds held a stake in Harpoon Therapeutics, Inc. (NASDAQ:HARP).
1. PLBY Group, Inc. (NASDAQ:PLBY) has risen 14.56% as of 12:40 PM ET after the pleasure and lifestyle company announced a common stock repurchase program. The Board of Directors of PLBY Group, Inc. (NASDAQ:PLBY) authorized a $50 million program after the company managed to secure financing due to preferred stock’s private placement.
Overall, 16 hedge funds held a stake in PLBY Group, Inc. (NASDAQ:PLBY) at the end of Q4 2021.
You can also take a peek at the 10 Dividend Growth Stocks Popular on Robinhood and 10 Oil Tanker Stocks That Pay Dividends.
